Related Experiment Video

Updated: Jun 29, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

7.1K

Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)

Wenhua Liang1,2, Kaican Cai3, Chun Chen4

  • 1Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.

Translational Lung Cancer Research
|February 4, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Simple and Effective Transplantation Device for Zebrafish Embryos
06:59

A Simple and Effective Transplantation Device for Zebrafish Embryos

Published on: August 2, 2021

4.1K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

995

Related Experiment Videos

Last Updated: Jun 29, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

7.1K
A Simple and Effective Transplantation Device for Zebrafish Embryos
06:59

A Simple and Effective Transplantation Device for Zebrafish Embryos

Published on: August 2, 2021

4.1K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

995

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Quality in Lung Cancer Surgery: A Structure-Process-Outcome Perspective.

Thoracic surgery clinics·2026

Beyond tumour size: Integrating tumour biology and technical quality to select the extent of resection in early-stage NSCLC.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026

Segmentectomy vs Lobectomy for Peripheral Early-Stage Non-Small Cell Lung Cancer in Patients With Radiologically High Risk Tumors.

Annals of thoracic surgery short reports·2026

Is Neoadjuvant Chemoimmunotherapy Safe in Surgically High-Risk Lung Cancer Patients? A Single-Centre IPTW Analysis.

Journal of clinical medicine·2026

European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy.

Lung cancer (Amsterdam, Netherlands)·2026

European analysis of patients with early-stage lung adenocarcinoma and invasive pathologic features who underwent lobectomy versus segmentectomy.

The Journal of thoracic and cardiovascular surgery·2026

Synergistic effects and molecular mechanisms of pirfenidone combined with EGFR-TKIs in non-small cell lung cancer.

Translational lung cancer research·2026

Multimodal digital assessment of early recovery after chest tube omission in early-stage lung cancer patients undergoing wedge resection: a post hoc analysis of a prospective cohort.

Translational lung cancer research·2026

A structural dose-response relationship between lymph node yield and survival after anatomical segmentectomy for early-stage NSCLC: a SEER-based retrospective cohort study.

Translational lung cancer research·2026

Retrospective real-world associations between EGFR alterations and furmonertinib outcomes in advanced non-small cell lung cancer.

Translational lung cancer research·2026

Bioelectrical impedance-derived body composition and systemic therapy outcomes in non-small cell lung cancer.

Translational lung cancer research·2026

Regional disparities in lung cancer surgery and survival in South Korea: a nationwide population-based retrospective cohort study using linked cancer registry and national health insurance data.

Translational lung cancer research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us